FDA Spied On Staff Without Considering Legal Risks: Report

Law360, New York (February 26, 2014, 6:36 PM EST) -- The U.S. Food and Drug Administration failed to explore legal implications before surveilling its scientists’ online activities to determine who was leaking the trade secrets of medical device makers as part of whistleblowing about safety concerns, the U.S. Government Accountability Office said Tuesday.

The GAO’s highly anticipated report concluded that regulators approved the monitoring in April 2010 without examining whether they might run afoul of the Fourth Amendment’s ban on unreasonable search and seizure. Ex-staffers, in a lawsuit playing out in Washington federal court, allege violations...
To view the full article, register now.




Case Information

Case Title

HARDY et al v. SHUREN et al

Case Number



District Of Columbia

Nature of Suit

Civil Rights: Other


Reggie B. Walton

Date Filed

September 28, 2011


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.